Trials / Conditions / Stage IV Rectal Cancer AJCC v7
Stage IV Rectal Cancer AJCC v7
5 registered clinical trials studyying Stage IV Rectal Cancer AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally NCT03300544 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That NCT03317119 | City of Hope Medical Center | Phase 1 |
| Completed | TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, o NCT03297710 | Mayo Clinic | Phase 1 |
| Completed | S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally NCT03365882 | SWOG Cancer Research Network | Phase 2 |
| Active Not Recruiting | Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy NCT02381561 | National Cancer Institute (NCI) | Phase 1 |